Protean eGov Technologies, Balaji Speciality Chemicals get Sebi nod for IPOs – Moneycontrol
My Account
Follow us on:
Powered By
Learn, discover & invest in smallcases across different types to build your long term portfolio.
Invest Now
Explore from India`s leading investment managers and advisors curating their strategies as smallcases.
Invest Now
Powered By ![]()
Diversify your portfolio by investing in Global brands.
Invest Now
Pre-configured baskets of stocks & ETFs that you can invest
in with a single click. Developed by hedge funds, global
asset management companies, experienced wealth
management firms and portfolio managers.
Invest Now![]()
AMBAREESH BALIGA
Fundamental, Stock Ideas, Multibaggers & Insights
Subscribe
CK NARAYAN
Stock & Index F&O Trading Calls & Market Analysis
Subscribe
SUDARSHAN SUKHANI
Technical Call, Trading Calls & Insights
Subscribe
T GNANASEKAR
Commodity Trading Calls & Market Analysis
Subscribe
MECKLAI FINANCIALS
Currency Derivatives Trading Calls & Insights
Subscribe
SHUBHAM AGARWAL
Options Trading Advice and Market Analysis
Subscribe
MARKET SMITH INDIA
Model portfolios, Investment Ideas, Guru Screens and Much More
Subscribe
TraderSmith
Proprietary system driven Rule Based Trading calls
Subscribe![]()
![]()
Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas
Subscribe
Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas
Explore
STOCK REPORTS BY THOMSON REUTERS
Details stock report and investment recommendation
Subscribe
POWER YOUR TRADE
Technical and Commodity Calls
Subscribe
INVESTMENT WATCH
Set price, volume and news alerts
Subscribe
STOCKAXIS EMERGING MARKET LEADERS
15-20 High Growth Stocks primed for price jumps
Subscribe
Protean eGov Technologies and Balaji Speciality Chemicals have received approval from the capital markets regulator Sebi to go ahead with IPO plans.
The proposed IPO of Protean, formerly known as NSDL E-Governance Infrastructure, comprises only an offer for sale of 1.2 crore shares by many selling shareholders, while the initial public offering of Balaji Speciality Chemicals consists of a fresh issue of Rs 250 crore and an offer for sale of 2.6 crore shares by promoters.
Protean received Sebi’s final observation letter on November 17 and Balaji Speciality on November 15, with respect to draft red herring prospectus filed in December last year and August this year, respectively.
As per the regulator, getting an observation letter implies that the company can float its IPO, and the proposed IPO can be launched for subscription by the company within a period of 12 months from the issuance of the letter.
Protean eGov Technologies
In the offer for sale of Protean eGov Technologies, IIFL Special Opportunities Fund, IIFL Special Opportunities Fund Series 2, Series 3, Series 4, and Series 5, Administrator of the Specified Undertaking of the Unit Trust of India, NSE Investments, HDFC Bank, Axis Bank, Deutsche Bank A.G., Punjab National Bank, and Union Bank of India together will sell 1.2 crore shares.
Hence, the company will not receive any money from the offer as all the money will go to above selling shareholders.
Click Here To Read All IPO Related News
ICICI Securities, Equirus Capital, IIFL Securities, and Nomura Financial Advisory and Securities (India) are the merchant bankers to the issue of Protean, the IT-enabled solution company having collaboration with the government.
The company is primarily engaged in conceptualising, developing and executing nationally critical and population scale greenfield technology solutions. As per CRISIL report, it was among the leading Indian companies in the e-governance sector in terms of profitability, operating income, operating profit and operating profit margin in FY20.
Balaji Speciality Chemicals
Balaji Speciality Chemicals, the subsidiary of Balaji Amines, is the sole manufacturer in India of niche chemicals such as ethylenediamine, piperazine (anhydrous), diethylenetriamine, amino ethyl ethanol amines and amino ethyl piperazine, using the monoethanol amine (MEA) process.
These chemicals are being used by sectors like speciality chemicals, agrochemicals, and pharmaceuticals.
The fresh issue proceeds will be utilised by the company for repaying debts and working capital requirements, besides general corporate purposes.
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.